InDevR
Company

Last deal

$9.M

Amount

Series B

Stage

17.01.2023

Date

4

all rounds

$19.M

Total amount

General

About Company
InDevR develops and manufactures microarray technologies and novel solutions for the life science industry.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2003

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The biotechnology company offers a range of microarray-related products, including next-generation diagnostic tools for tracking influenza viruses, viral vaccines, conjugate vaccines, mRNA vaccines, cell and gene therapy, and therapeutic antibodies. In addition, InDevR provides testing and custom development services to support vaccine research, development, and manufacturing.
Contacts

Social url